PLAYSTUDIOS INC (MYPS) Stock Fundamental Analysis

NASDAQ:MYPS • US72815G1085

0.5135 USD
+0.01 (+2.95%)
Last: Mar 3, 2026, 03:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, MYPS scores 4 out of 10 in our fundamental rating. MYPS was compared to 80 industry peers in the Entertainment industry. While MYPS has a great health rating, there are worries on its profitability. MYPS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MYPS has reported negative net income.
  • MYPS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MYPS reported negative net income in multiple years.
  • In the past 5 years MYPS always reported a positive cash flow from operatings.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • MYPS's Return On Assets of -12.49% is on the low side compared to the rest of the industry. MYPS is outperformed by 71.25% of its industry peers.
  • The Return On Equity of MYPS (-15.64%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.49%
ROE -15.64%
ROIC N/A
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • Looking at the Gross Margin, with a value of 75.01%, MYPS belongs to the top of the industry, outperforming 83.75% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MYPS has grown nicely.
  • The Profit Margin and Operating Margin are not available for MYPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MYPS has been reduced compared to 1 year ago.
  • The number of shares outstanding for MYPS has been reduced compared to 5 years ago.
  • There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • MYPS has an Altman-Z score of 1.50. This is a bad value and indicates that MYPS is not financially healthy and even has some risk of bankruptcy.
  • MYPS has a Altman-Z score of 1.50. This is comparable to the rest of the industry: MYPS outperforms 58.75% of its industry peers.
  • There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.5
ROIC/WACCN/A
WACC9.05%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • MYPS has a Current Ratio of 3.91. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.91, MYPS belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • MYPS has a Quick Ratio of 3.91. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
  • MYPS has a better Quick ratio (3.91) than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.91
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for MYPS have decreased strongly by -47.37% in the last year.
  • Looking at the last year, MYPS shows a very negative growth in Revenue. The Revenue has decreased by -17.17% in the last year.
  • MYPS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.87% yearly.
EPS 1Y (TTM)-47.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-17.17%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-19.07%

3.2 Future

  • MYPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.65% yearly.
  • MYPS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.05% yearly.
EPS Next Y25.82%
EPS Next 2Y23.2%
EPS Next 3Y25.65%
EPS Next 5YN/A
Revenue Next Year-18.41%
Revenue Next 2Y-10.24%
Revenue Next 3Y-6.74%
Revenue Next 5Y-5.05%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • MYPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MYPS is valued cheaply inside the industry as 96.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.67
EV/EBITDA -1.67
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • MYPS's earnings are expected to grow with 25.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.2%
EPS Next 3Y25.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MYPS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLAYSTUDIOS INC

NASDAQ:MYPS (3/3/2026, 3:23:51 PM)

0.5135

+0.01 (+2.95%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-03
Earnings (Next)03-16
Inst Owners36.05%
Inst Owner Change2.91%
Ins Owners3.04%
Ins Owner Change0.07%
Market Cap64.75M
Revenue(TTM)247.48M
Net Income(TTM)-37.36M
Analysts78.18
Price Target1.79 (248.59%)
Short Float %2.9%
Short Ratio9.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-134.4%
Min EPS beat(2)-217.96%
Max EPS beat(2)-50.83%
EPS beat(4)0
Avg EPS beat(4)-98.55%
Min EPS beat(4)-217.96%
Max EPS beat(4)-15.34%
EPS beat(8)2
Avg EPS beat(8)-125.74%
EPS beat(12)6
Avg EPS beat(12)-57.8%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.72%
Min Revenue beat(2)-5.61%
Max Revenue beat(2)-3.84%
Revenue beat(4)0
Avg Revenue beat(4)-3.8%
Min Revenue beat(4)-5.61%
Max Revenue beat(4)-1.44%
Revenue beat(8)3
Avg Revenue beat(8)-2.22%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)7
Avg Revenue beat(16)-0.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.9%
EPS NY rev (1m)-30.61%
EPS NY rev (3m)-106.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF 3.67
P/OCF 1.89
P/B 0.27
P/tB 0.61
EV/EBITDA -1.67
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.14
FCFY27.28%
OCF(TTM)0.27
OCFY52.84%
SpS1.96
BVpS1.89
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.49%
ROE -15.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.01%
FCFM 7.14%
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.05%
Cap/Sales 6.69%
Interest Coverage N/A
Cash Conversion 131.78%
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.91
Altman-Z 1.5
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)71.79%
Cap/Depr(5y)97.26%
Cap/Sales(3y)9.92%
Cap/Sales(5y)10.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y25.82%
EPS Next 2Y23.2%
EPS Next 3Y25.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.17%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-19.07%
Revenue Next Year-18.41%
Revenue Next 2Y-10.24%
Revenue Next 3Y-6.74%
Revenue Next 5Y-5.05%
EBIT growth 1Y-108.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year270.38%
EBIT Next 3Y54.04%
EBIT Next 5Y49.12%
FCF growth 1Y76.8%
FCF growth 3YN/A
FCF growth 5Y16.46%
OCF growth 1Y-11.24%
OCF growth 3Y10.52%
OCF growth 5Y4.85%

PLAYSTUDIOS INC / MYPS FAQ

What is the fundamental rating for MYPS stock?

ChartMill assigns a fundamental rating of 4 / 10 to MYPS.


What is the valuation status for MYPS stock?

ChartMill assigns a valuation rating of 2 / 10 to PLAYSTUDIOS INC (MYPS). This can be considered as Overvalued.


How profitable is PLAYSTUDIOS INC (MYPS) stock?

PLAYSTUDIOS INC (MYPS) has a profitability rating of 3 / 10.


What is the expected EPS growth for PLAYSTUDIOS INC (MYPS) stock?

The Earnings per Share (EPS) of PLAYSTUDIOS INC (MYPS) is expected to grow by 25.82% in the next year.